Evidence map›Paper›PMID 24002163›Full record

ArticleEuropean journal of human genetics : EJHG2014

Haplotype structure and positive selection at TLR1.

Christopher Heffelfinger, Andrew J Pakstis, William C Speed, Allison P Clark, Eva Haigh, Rixun Fang, Mahohar R Furtado, Kenneth K Kidd, Michael P Snyder

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genetic variation in Tunisia in the context of human diversity worldwide.American journal of physical anthropology · 2016
    Article
  9. Article
  10. Article
  11. Molecular characterization and analysis of TLR-1 in rabbit tissues.Central-European journal of immunology · 2016
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Christopher Heffelfinger1] Department of Genetics, Yale University, New Haven, CT, USA [2] Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.
Andrew J PakstisDepartment of Genetics, Yale University, New Haven, CT, USA.
William C SpeedDepartment of Genetics, Yale University, New Haven, CT, USA.
Allison P ClarkDepartment of Genetics, Yale University, New Haven, CT, USA.
Eva HaighDepartment of Genetics, Yale University, New Haven, CT, USA.
Rixun FangLife Technologies, Foster City, CA, USA.
Mahohar R Furtado1] Life Technologies, Foster City, CA, USA [2] President & Founder, Biology for Global Good, Sam Ramon, CA, USA.ORCID 0000000250000856
Kenneth K KiddDepartment of Genetics, Yale University, New Haven, CT, USA.
Michael P SnyderDepartment of Genetics, Stanford University, Palo Alto, CA, USA.
Yale University · USStanford University · USThermo Fisher Scientific (Norway) · NO

Funding

Skill Development for Diverse Scientific Careers: A New Course Predoctoral Program in Cellular and Molecular BiologyT32GM007223 · NIGMS · YALE UNIVERSITY · PI BASERGA, SUSAN J · 1985 to 2019
$31.0M
Theoretical Studies of Linkage DisequilibriumP01GM057672 · NIGMS · YALE UNIVERSITY · PI KIDD, JUDITH R · 1998 to 2008
$11.0M
NIGMS NIH HHS 5T32 GM007223NIGMS NIH HHS GM057672NIGMS NIH HHS P01 GM057672NIGMS NIH HHS T32 GM007223
6 · The paper itself

Abstract

Toll-like receptor 1, when dimerized with Toll-like receptor 2, is a cell surface receptor that, upon recognition of bacterial lipoproteins, activates the innate immune system. Variants in TLR1 associate with the risk of a variety of medical conditions and diseases, including sepsis, leprosy, tuberculosis, and others. The foremost of these is rs5743618 c.2079T>G(p.(Ile602Ser)), the derived allele of which is associated with reduced risk of sepsis, leprosy, and other diseases. Interestingly, 602Ser, which shows signatures of selection, inhibits TLR1 surface trafficking and subsequent activation of NFκB upon recognition of a ligand. This suggests that reduced TLR1 activity may be beneficial for human health. To better understand TLR1 variation and its link to human health, we have typed all 7 high-frequency missense variants (>5% in at least one population) along with 17 other variants in and around TLR1 in 2548 individuals from 56 populations from around the globe. We have also found additional signatures of selection on missense variants not associated with rs5743618, suggesting that there may be multiple functional alleles under positive selection in this gene.

Indexed as

HaplotypesAllelesGenetic LociHumansLinkage DisequilibriumMutation, MissenseNF-kappa BPolymorphism, Single NucleotideReceptors, Cell SurfaceSelection, GeneticToll-Like Receptor 1NF-kappa BReceptors, Cell SurfaceToll-Like Receptor 1

Identifiers

PMID24002163
PMCPMC3953919
OpenAlexW2010504502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.